Johnson Matthey (OTCMKTS:JMPLY) Upgraded to Hold at Zacks Research

Key Points

• Johnson Matthey's stock rating has been upgraded from a "strong sell" to a "hold" by Zacks Research.
• Kepler Capital Markets also raised their rating on Johnson Matthey to a "hold", bringing the average rating for the stock to "hold" according to MarketBeat.com.
• As of the latest trading, Johnson Matthey shares reached $50.07, showing a notable increase, and its recent stock performance reflects a strong 12-month high of $50.88.

Johnson Matthey (OTCMKTS:JMPLY - Get Free Report) was upgraded by investment analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a report issued on Monday,Zacks.com reports.

Separately, Kepler Capital Markets raised shares of Johnson Matthey to a "hold" rating in a research report on Wednesday, June 25th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of "Hold".

Johnson Matthey Stock Performance

JMPLY remained flat at $50.90 during trading on Monday. 128 shares of the company's stock were exchanged, compared to its average volume of 869. The company has a current ratio of 1.42, a quick ratio of 1.01 and a debt-to-equity ratio of 0.57. The company has a 50 day simple moving average of $48.73 and a 200-day simple moving average of $41.22. Johnson Matthey has a twelve month low of $29.01 and a twelve month high of $50.90.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.